- Home
- HIMS
as 05-08-2025 4:00pm EST
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, haircare and more.
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | SAN FRANCISCO |
| Market Cap: | 6.0B | IPO Year: | N/A |
| Target Price: | $37.67 | AVG Volume (30 days): | 44.9M |
| Analyst Decision: | Hold | Number of Analysts: | 12 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.68 | EPS Growth: | N/A |
| 52 Week Low/High: | $12.07 - $72.98 | Next Earning Date: | 05-05-2025 |
| Revenue: | $1,784,353,000 | Revenue Growth: | 85.99% |
| Revenue Growth (this year): | 60.78% | Revenue Growth (next year): | 18.96% |
Stock Insider Trading Activity of Hims & Hers Health Inc. (HIMS)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Dudum Andrew | HIMS | Chief Executive Officer | Apr 28 '25 | Sell | $33.29 | 91,667 | $3,077,070.06 | 92,103 | |
| Boughton Soleil | HIMS | Chief Legal Officer | Apr 28 '25 | Sell | $30.19 | 3,236 | $97,694.84 | 159,662 | |
| Becklund Irene | HIMS | PAO | Apr 22 '25 | Sell | $26.49 | 2,936 | $77,774.64 | 5,071 | |
| Baird Melissa | HIMS | Chief Operating Officer | Apr 21 '25 | Sell | $25.97 | 33,333 | $859,256.11 | 811,381 | |
| Dudum Andrew | HIMS | Chief Executive Officer | Apr 16 '25 | Sell | $28.19 | 83,994 | $2,364,547.13 | 92,103 | |
| Baird Melissa | HIMS | Chief Operating Officer | Apr 9 '25 | Sell | $27.63 | 33,337 | $910,687.46 | 811,381 | |
| Becklund Irene | HIMS | PAO | Apr 3 '25 | Sell | $28.78 | 2,203 | $63,402.34 | 5,071 | |
| Okupe Oluyemi | HIMS | Chief Financial Officer | Apr 2 '25 | Sell | $29.26 | 11,581 | $338,833.42 | 124,104 | |
| Boughton Soleil | HIMS | Chief Legal Officer | Mar 31 '25 | Sell | $27.77 | 3,236 | $89,863.72 | 159,662 | |
| Baird Melissa | HIMS | Chief Operating Officer | Mar 26 '25 | Sell | $35.48 | 67,687 | $2,358,144.87 | 811,381 |
Latest Hims & Hers Health Inc. News
HIMS Breaking Stock News: Dive into HIMS Ticker-Specific Updates for Smart Investing
Business Wire
a day ago
Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to Accelerate Global Expansion and Utilization of AI in Healthcare
Business Wire
a day ago
Hims & Hers Appoints AI Expert and Former President and CTO at Cruise as Chief Technology Officer
Simply Wall St.
2 days ago
Hims & Hers Health First Quarter 2025 Earnings: Beats Expectations
Yahoo Finance
2 days ago
Novo Nordisk beats on Q1 earnings, cuts 2025 outlook
TipRanks
2 days ago
Hims & Hers Stock (HIMS) Falls as Cautious Outlook Blurs Massive Revenue Growth
Argus Research
2 days ago
HIMS: Rating decreased to a HOLD
Bloomberg
3 days ago
Stocks Fall as Tariff Angst Spurs Gains in Bonds: Markets Wrap
Investor's Business Daily
3 days ago
Leading Weight-Loss Stock, Hims & Hers, Shrugs Off Outlook Worries And Spikes 18%
Compare HIMS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HIMS Hims & Hers Health Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.